Hasil Pencarian - Sallyann Vu

  • Menampilkan 1 - 2 hasil dari 2
Perbaiki Hasil
  1. 1
    1056 XTX301, a tumor activated, half-life extended IL-12 promoted potent anti-tumor immunity and activity across multiple syngeneic tumor models

    1056 XTX301, a tumor activated, half-life extended IL-12 promoted potent anti-tumor immunity and activity across multiple syngeneic tumor models oleh Wilson Guzman, Damiano Fantini, Parker Johnson, Kurt Jenkins, Hanumantha Rao Madala, Caitlin O’Toole, Magali Pederzoli-Ribeil, Jennifer O’Neil, Jake Taylor, Ekta Patel, Sallyann Vu, Manoussa Fanny, Oleg Yerov, Benjamin Nicholson, Natalia V Malkova, Stephanie Hsiao, Ertan Eryilmaz, Uli Bialucha

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    719 XTX301, a protein-engineered IL-12, exhibits tumor-selective activity in mice without peripheral toxicities and is well tolerated in non-human primates

    719 XTX301, a protein-engineered IL-12, exhibits tumor-selective activity in mice without peripheral toxicities and is well tolerated in non-human primates oleh Jia Chen, Wilson Guzman, Parker Johnson, Megan McLaughlin, Kurt Jenkins, Hanumantha Rao Madala, Magali Pederzoli-Ribeil, Huawei Qiu, Ekta Patel, Natalia Malkova, Sallyann Vu, Rebekah O'Donnell, Manoussa Fanny, Oleg Yerov, Caitlin O'Toole, Benjamin Nicholson, Bill Avery, Ronan O'Hagan, Jennifer O'Neil

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: